Yes, it's Trump's fault
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
L'Oreal says weight loss drugs are impacting beauty and skin care sales
POLL
Voting on: L'Oreal says weight loss drugs are impacting beauty and skin care sales
Poll
All Responses
Hung jury.
Yes, it's Trump's fault
No, it's not Trump's fault
Too soon to tell
0 verified votes
Yes, it's Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
No, it's not Trump's fault
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
A plausible opening argument escalates into an extreme case against Trump.
Real event · international · 2026-10-22
Final verdict announced: October 23, 2026 at 8:02 PM ET
L'Oreal says weight loss drugs are impacting beauty and skin care sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us."
Original reporting
The CEO's statement highlights the impact of weight loss drugs.
Satirical commentary is temporarily unavailable. The sourced facts remain available above.